Boost for AstraZeneca good news for FTSE
Drugs giant AstraZeneca eased the pressure on the FTSE 100 Index today after its anti-cholesterol drug Crestor received a boost from regulators.
The heavyweight stock soared after America’s Food and Drug Administration ruled that Crestor – one of the key products in its portfolio – did not have a greater risk of side-effects than similar drugs.